about
Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine ApproachA chimeric 18L1-45RG1 virus-like particle vaccine cross-protects against oncogenic alpha-7 human papillomavirus types.Efficacy of RG1-VLP vaccination against infections with genital and cutaneous human papillomaviruses.Establishment of an in vitro equine papillomavirus type 2 (EcPV2) neutralization assay and a VLP-based vaccine for protection of equids against EcPV2-associated genital tumors.
P50
description
researcher ORCID ID = 0000-0002-8086-7848
@en
wetenschapper
@nl
name
Bettina Huber
@ast
Bettina Huber
@en
Bettina Huber
@es
Bettina Huber
@nl
type
label
Bettina Huber
@ast
Bettina Huber
@en
Bettina Huber
@es
Bettina Huber
@nl
prefLabel
Bettina Huber
@ast
Bettina Huber
@en
Bettina Huber
@es
Bettina Huber
@nl
P106
P31
P496
0000-0002-8086-7848